ANALYTICAL METHODS FOR THE RECENTLY APPROVED FDA NEW MOLECULAR ENTITIES – A REVIEW
Author(s) -
Sreenivasa C Archakam,
Sridhar Chenchugari,
Chandra S Kothapalli Banoth
Publication year - 2016
Publication title -
journal of comprehensive pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2349-5669
DOI - 10.37483/jcp.2016.3301
Subject(s) - data science , management science , computer science , engineering ethics , medicine , engineering
Analytical method development and validation for the analysis therapeutic components and associated substances play an important role in the discovery, development and manufacture of pharmaceuticals and natural medicinal compounds. Pharmaceutical and herbal products formulated with more than one drug, typically referred to as combination products, are intended to meet previously unmet patients need by combining the therapeutic effects of two or more drugs in a single dosage. The new chemical entities and combination products can present daunting challenges to the analytical chemist responsible for the development and validation of analytical methods. The official test methods that result from these processes are used by quality control laboratories to ensure the identity, purity, potency, and performance of drug products [1].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom